Moreover, AKT-inhibited CD8+ T cells should be expanded in the absence of CD4+ T cells, where CD4+ T cells could be expanded separately with or without AKT-inhibition, followed by co-infusion for therapy of cancer patients. Here, CD8A is linked to cancer.